What is the CIHR Centre for REACH in HIV/AIDS?

 

A virtual laboratory.

We are a nation-wide, innovative, virtual laboratory for intervention research, participatory evaluation, and applied program science in HIV/AIDS, Hepatitis C, and other sexually transmitted and bloodborne infections.

A partnership.

We work as a partnership that includes people living with HIV/AIDS, community based organizations, front-line service providers, health researchers, and federal, provincial, and regional policy makers.

A collaboration.

We provide the national-level infrastructure that allows our members to collaborate across geographic boundaries. Our goal is to create and support inter-professional research, policy, and community teams that will:

  1. Identify the range of existing effective interventions, focusing on interventions that address the needs of the populations most affected by HIV, other STIs, and Hepatitis C.
  2. Provide support and expertise for front-line organizations and service providers in the evaluation of their programs and services.
  3. Identify gaps in the implementation, scale-up, and sustainability of effective interventions, and support research to develop packages of interventions.
  4. Actively engage in applied program science, working regionally to: appraise local HIV, STI and Hepatitis C epidemics; adapt effective interventions for different Canadian contexts; assess the feasibility, effectiveness and cost-effectiveness of interventions; and identify factors that might affect scale-up and sustainability.
  5. Create a strong embedded training and capacity building program in community-based research, intervention research, participatory evaluation, and program science.
  6. Develop a research and program science partnership among funded centres to maximize the impact of research and knowledge translation resources.

We are funded by the Canadian Institutes of Health Research, and we work with Regional Core Teams and official partners across the country. We are committed to community-based research models and to the greater and more meaningful involvement of people living with HIV, other STIs, and Hepatitis C.